loading
Kiniksa Pharmaceuticals International Plc stock is traded at $21.16, with a volume of 192.55K. It is down -0.47% in the last 24 hours and down -19.31% over the past month. Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
See More
Previous Close:
$21.29
Open:
$21.02
24h Volume:
192.55K
Relative Volume:
0.55
Market Cap:
$1.51B
Revenue:
$384.10M
Net Income/Loss:
$-9.07M
P/E Ratio:
-192.36
EPS:
-0.11
Net Cash Flow:
$11.10M
1W Performance:
-8.03%
1M Performance:
-19.31%
6M Performance:
+7.18%
1Y Performance:
+34.88%
1-Day Range:
Value
$20.58
$21.48
1-Week Range:
Value
$20.58
$23.34
52-Week Range:
Value
$15.51
$28.15

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name
Name
Kiniksa Pharmaceuticals International Plc
Name
Phone
-
Name
Address
-
Name
Employee
297
Name
Twitter
@kiniksa
Name
Next Earnings Date
2024-10-29
Name
Latest SEC Filings
Name
KNSA's Discussions on Twitter

Compare KNSA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
KNSA 21.19 1.51B 384.10M -9.07M 11.10M -0.11
ZTS 176.43 79.52B 9.15B 2.43B 2.31B 4.92
TAK 13.54 43.13B 30.27B 1.93B 3.45B 0.444
HLN 9.425 42.57B 14.26B 1.55B 0 0.3327
TEVA 16.46 18.56B 16.77B -959.00M 1.37B -2.00
VTRS 12.99 15.37B 15.24B -646.50M 1.88B 1.53

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-29-20 Reiterated BofA Securities Buy
Apr-01-20 Initiated BofA/Merrill Buy
Mar-11-19 Initiated Barclays Overweight
Dec-12-18 Reiterated Wedbush Outperform
Jun-19-18 Initiated JMP Securities Mkt Outperform

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News

pulisher
Nov 13, 2024

Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025? - Insider Monkey

Nov 13, 2024
pulisher
Nov 12, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference 2024 | KNSA Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

10 Top Performing European Stocks Heading into 2025 - Insider Monkey

Nov 12, 2024
pulisher
Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Nov 04, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Trading Down 3. - GuruFocus.com

Nov 04, 2024
pulisher
Nov 01, 2024

Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earning - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Kiniksa Pharmaceuticals Reports Strong Q3 2024 Growth - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ... - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Kiniksa Pharm's Revenue Surges 67% in Q3 - The Motley Fool

Oct 29, 2024
pulisher
Oct 29, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Shares Gap Down to $24.04 on Oct 29 - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Kiniksa Pharmaceuticals Q3 2024 Earnings: EPS Miss, Revenue Beats Estimates with $112.2 Million - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 28, 2024

Exploring Kiniksa Pharmaceuticals's Earnings Expectations - Benzinga

Oct 28, 2024
pulisher
Oct 28, 2024

What To Expect From Kiniksa Pharmaceuticals International PLC (K - GuruFocus.com

Oct 28, 2024
pulisher
Oct 28, 2024

What To Expect From Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis - StockTitan

Oct 28, 2024
pulisher
Oct 22, 2024

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024 - GlobeNewswire

Oct 22, 2024
pulisher
Oct 19, 2024

Kiniksa Pharmaceuticals COO Eben sells shares worth $456,790 - Investing.com India

Oct 19, 2024
pulisher
Oct 17, 2024

Kiniksa Pharmaceuticals COO Eben sells shares worth $456,790 By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 15, 2024

High Growth Tech Stocks To Watch In October 2024 - Simply Wall St

Oct 15, 2024
pulisher
Oct 11, 2024

What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing' - Yahoo Finance

Oct 11, 2024
pulisher
Oct 08, 2024

Baker Bros. Advisors LP Increases Stake in Kiniksa Pharmaceuticals - Yahoo Finance

Oct 08, 2024
pulisher
Oct 08, 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives Average Rating of “Buy” from Analysts - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

Kiniksa Pharmaceuticals: Looking In On A Developing Growth Story (NASDAQ:KNSA) - Seeking Alpha

Oct 07, 2024
pulisher
Oct 01, 2024

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis - The Manila Times

Oct 01, 2024
pulisher
Oct 01, 2024

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa - GlobeNewswire

Oct 01, 2024
pulisher
Sep 25, 2024

Kiniksa Pharmaceuticals COO sells shares worth over $437,000 By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 25, 2024

Kiniksa Pharmaceuticals COO sells shares worth over $437,000 - Investing.com

Sep 25, 2024
pulisher
Sep 23, 2024

Kiniksa Pharmaceuticals International Plc. (KNSA) looking to reclaim success with recent performance - SETE News

Sep 23, 2024
pulisher
Sep 21, 2024

Rubric Capital Management LP Acquires 223,094 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World

Sep 21, 2024
pulisher
Sep 17, 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Sold by Acadian Asset Management LLC - Defense World

Sep 17, 2024
pulisher
Sep 13, 2024

Kiniksa stock draws buy at Jefferies (NASDAQ:KNSA) - Seeking Alpha

Sep 13, 2024
pulisher
Sep 10, 2024

Insider Sale Alert: Kiniksa Pharmaceuticals International Plc. [KNSA] – Is it Time to sell? - Knox Daily

Sep 10, 2024
pulisher
Sep 05, 2024

Kiniksa Pharmaceuticals exec sells over $1.7m in shares By Investing.com - Investing.com Australia

Sep 05, 2024
pulisher
Sep 04, 2024

Kiniksa Pharmaceuticals exec sells over $1.7m in shares - Investing.com India

Sep 04, 2024
pulisher
Sep 02, 2024

The Psychology of Kiniksa Pharmaceuticals International Plc. Inc. (KNSA) Price Performance: Understanding Market Sentiment - The InvestChronicle

Sep 02, 2024
pulisher
Aug 31, 2024

Eben Tessari Sells 17,500 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock - Defense World

Aug 31, 2024
pulisher
Aug 29, 2024

Kiniksa Pharmaceuticals COO sells shares worth over $470k - Investing.com

Aug 29, 2024
pulisher
Aug 28, 2024

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference - GlobeNewswire

Aug 28, 2024
pulisher
Aug 22, 2024

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 52-Week High at $27.96 - Defense World

Aug 22, 2024
pulisher
Aug 20, 2024

KNSA (Kiniksa Pharmaceuticals International) Property, Plan - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

Wells Fargo analysts initates an Overweight rating for Kiniksa Pharmaceuticals International Plc. (KNSA) - Knox Daily

Aug 19, 2024
pulisher
Aug 19, 2024

Stocks of Kiniksa Pharmaceuticals International Plc. (KNSA) are poised to climb above their peers - SETE News

Aug 19, 2024
pulisher
Aug 19, 2024

3 'Strong Buy' Small-Cap Stocks to Snag Now for a Soft Landing - Inkl

Aug 19, 2024

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Patel Sanj K
CHAIRMAN & CEO
Nov 06 '24
Sale
23.00
89,561
2,059,903
79,551
$76.27
price down icon 0.72%
$13.36
price down icon 4.36%
$81.94
price down icon 1.56%
$58.72
price down icon 0.65%
$117.38
price up icon 0.26%
$12.79
price down icon 0.97%
Cap:     |  Volume (24h):